tradingkey.logo
tradingkey.logo
Search

Vivos Therapeutics Inc

VVOS
Add to Watchlist
0.453USD
-0.045-9.05%
Close 07/02, 13:00ETQuotes delayed by 15 min
4.21MMarket Cap
LossP/E TTM

Vivos Therapeutics Inc

0.453
-0.045-9.05%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-9.05%

5 Days

+1.25%

1 Month

-34.56%

6 Months

-82.09%

Year to Date

-77.67%

1 Year

-89.77%

Key Figures
0.483Open
0.508High
400.62KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.31%Turnover Ratio
0.498Prev. Close
0.445Low
115.58KTurnover
LossP/E Static
-2.82P/B
0.00%Div Yield TTM
-138.29%ROA
7.95052wk High
0.23Volume Ratio
-11.14MNet Profit
9.29MShares
-2.1360EPS TTM
6.09Beta
-1528.79%ROE
0.54552wk Low
12.70%Amplitude
50.67%Gross Margin
4.21MMarket Cap
-4.64Reward/Risk
6.05%Risk Rate

Key Insights

Vivos Therapeutics Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 133 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.45.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Vivos Therapeutics Inc's Score

Industry at a Glance

Industry Ranking
133 / 204
Overall Ranking
324 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Vivos Therapeutics Inc Highlights

StrengthsRisks
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.39% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 17.44M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 17.44M.
Overvalued
The company’s latest PE is -0.21, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.10M shares, decreasing 6.15% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 5.05.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
2.450
Target Price
+391.67%
Upside Space

Vivos Therapeutics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Vivos Therapeutics Inc Info

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Ticker SymbolVVOS
CompanyVivos Therapeutics Inc
CEOHuntsman (R. Kirk)
Websitehttps://vivos.com/

FAQs

What is the current price of Vivos Therapeutics Inc (VVOS)?

The current price of Vivos Therapeutics Inc (VVOS) is 0.45.

What is the symbol of Vivos Therapeutics Inc?

The ticker symbol of Vivos Therapeutics Inc is VVOS.

What is the 52-week high of Vivos Therapeutics Inc?

The 52-week high of Vivos Therapeutics Inc is 7.95.

What is the 52-week low of Vivos Therapeutics Inc?

The 52-week low of Vivos Therapeutics Inc is 0.55.

What is the market capitalization of Vivos Therapeutics Inc?

The market capitalization of Vivos Therapeutics Inc is 4.21M.

Is Vivos Therapeutics Inc (VVOS) currently rated as Buy, Hold, or Sell?

According to analysts, Vivos Therapeutics Inc (VVOS) has an overall rating of Buy, with a price target of 2.45.

What is the Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS)?

The Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS) is -2.06.